Tetraspanins at a glance

S Charrin, S Jouannet, C Boucheix… - Journal of cell …, 2014 - journals.biologists.com
Tetraspanins are a family of proteins with four transmembrane domains that play a role in
many aspects of cell biology and physiology; they are also used by several pathogens for …

Tetraspanins function as regulators of cellular signaling

CM Termini, JM Gillette - Frontiers in cell and developmental biology, 2017 - frontiersin.org
Tetraspanins are molecular scaffolds that distribute proteins into highly organized
microdomains consisting of adhesion, signaling, and adaptor proteins. Many reports have …

Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature

S Mathivanan, JWE Lim, BJ Tauro, H Ji… - Molecular & cellular …, 2010 - ASBMB
Exosomes are 40–100-nm-diameter nanovesicles of endocytic origin that are released from
diverse cell types. To better understand the biological role of exosomes and to avoid …

Tetraspanins: push and pull in suppressing and promoting metastasis

M Zöller - Nature Reviews Cancer, 2009 - nature.com
Tumours progress through a cascade of events that enable the formation of metastases.
Some of the components that are required for this fatal process are well established …

Akt-ing up just about everywhere: compartment-specific Akt activation and function in receptor tyrosine kinase signaling

MG Sugiyama, GD Fairn, CN Antonescu - Frontiers in Cell and …, 2019 - frontiersin.org
The serine/threonine kinase Akt is a master regulator of many diverse cellular functions,
including survival, growth, metabolism, migration, and differentiation. Receptor tyrosine …

Prostate cancer sheds the αvβ3 integrin in vivo through exosomes

SR Krishn, A Singh, N Bowler, AN Duffy, A Friedman… - Matrix Biology, 2019 - Elsevier
The αvβ3 integrin has been shown to promote aggressive phenotypes in many types of
cancers, including prostate cancer. We show that GFP-labeled αvβ3 derived from cancer …

Antibodies targeting cancer stem cells: a new paradigm in immunotherapy?

MP Deonarain, CA Kousparou, AA Epenetos - MAbs, 2009 - Taylor & Francis
Antibody targeting of cancer is showing clinical and commercial success after much intense
research and development over the last 30 years. They still have the potential to delivery …

The tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progression

H Lazareth, C Henique, O Lenoir, VG Puelles… - Nature …, 2019 - nature.com
The mechanisms driving the development of extracapillary lesions in focal segmental
glomerulosclerosis (FSGS) and crescentic glomerulonephritis (CGN) remain poorly …

CD9, a tetraspanin target for cancer therapy?

A Lorico, M Lorico-Rappa… - Experimental …, 2021 - journals.sagepub.com
In the present minireview, we intend to provide a brief history of the field of CD9 involvement
in oncogenesis and in the metastatic process of cancer, considering its potential value as a …

Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion

E Guerra, V Relli, M Ceci, R Tripaldi, P Simeone… - Oncogene, 2022 - nature.com
Trop-2 is a transmembrane signal transducer that is overexpressed in most human cancers,
and drives malignant progression. To gain knowledge on the higher-order molecular …